Are all melanomas dangerous?

Acta Dermato-Venereologica

Volumn 91, Issue 5, 2011, Pages 499-503

  Nørgaard, Carsten ^a   Glud, Martin ^a   Gniadecki, Robert ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Incidence; Melanoma; Mortality; Thickness

Indexed keywords

CANCER STAGING; EPIDEMIC; HUMAN; INCIDENCE; MELANOMA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 80051994569     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1177     Document Type: Review

References (26)

1. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
2. Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Arch Dermatol 1999; 135: 275-280.
3. Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc 1997; 72: 559-564.
4. Beddingfield FC. The melanoma epidemic: res ipsa loquitur. Oncologist 2003; 8: 459-465.
5. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-613.
6. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma-population based ecological study. BMJ 2005; 331: 481.
7. Shuster S. Malignant melanoma: how error amplification by screening creates spurious disease. Br J Dermatol 2009; 161: S33-39.
8. Erickson C, Driscoll MS. Melanoma epidemic: facts and controversies. Clin Dermatol 2010; 28: 281-286.
9. Metelitsa AI, Dover DC, Smylie M, de Gara CJ, Lauzon GJ. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002). J Am Acad Dermatol 2010; 62: 227-232.
10. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009; 12: 1666-1674.
11. Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009; 161: 630-634.
12. Tryggvadóttir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 665-672.
13. Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 545-560.
14. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006; 17: 21-27.
15. MacKie RM, Bray C, Vestey J, Doherty V, Evans A, Thom-son D, et al. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007; 96: 1772-1777.
16. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer 2006; 95: 91-95.
17. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer 2009; 45: 2360-2366.
18. Burton RC, Armstrong BK. Current melanoma epidemic: a nonmetastasizing form of melanoma? World J Surg 1995; 19: 330-333.
19. Theobald T, Marks R, Hill D, Dorevitch A. "Goodbye Sunshine": effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. J Am Acad Dermatol 1991; 25: 717-723.
20. Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database Syst Rev 2006; 3: CD004720.
21. Stratigos AJ, Katsambas AD. The value of screening in melanoma. Clin Dermatol 2009; 27: 10-25.
22. Stamatiou K, Alevizos A, Agapitos E, Sofras F. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study. Prostate 2006; 66: 1319-1328.
23. Solares CA, Penalonzo MA, Xu M, Orellana E. Occult papillary thyroid carcinoma in postmortem species: prevalence at autopsy. Am J Otolaryngol 2005; 26: 87-90.
24. Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J, et al. Patterns of detection in patients with cutaneous melanoma. Cancer 2000; 89: 342-347.
25. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, et al. Self-detected cutaneous melanomas in Italian patients. Clin Exp Dermatol 2004; 29: 593-596.
26. Lasithiotakis KG, Petrakis IE, Garbe C. Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res 2010; 20: 163-170.